Dr. Sennewald Medizintechnik
Tuesday , September 14, 2010
12h45 – 14h15
Room 115 - Level 1

Lunch and drinks are courtesy of Dr. Sennewald

Hyperthermia – the 4th Column in Cancer Treatment
Chair: Peter Levendag, Rotterdam, The Netherlands
           Olav Dahl, Bergen, Norway

12.45 – 12.55 Welcome and Introduction
                       Chairmen

12.55 – 13.15 Immunological and biological rationale for hyperthermia in cancer treatment
                       Udo Gaipl, Erlangen, Germany

13.15 – 13.20 Discussion

13.20 – 13.40 Where is hyperthermia already standard in clinical practice?
                       Martine Franckena, Rotterdam, The Netherlands

13.40 – 13.45 Discussion

13.45 – 14.05 Physical and technological potentials of deep RF hyperthermia
                       Peter Wust, Berlin, Germany

14.05 – 14.10 Discussion

14.10 – 14.15 Closing Remarks